Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men.
Decensi, A U
Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men. [electronic resource] - The Journal of urology Nov 1989 - 1235-8 p. digital
Publication Type: Journal Article
0022-5347
10.1016/s0022-5347(17)39042-0 doi
17-alpha-Hydroxyprogesterone
Aged
Antineoplastic Agents--adverse effects
Chorionic Gonadotropin
Follicle Stimulating Hormone--metabolism
Gonadotropin-Releasing Hormone--adverse effects
Humans
Hydroxyprogesterones--metabolism
Luteinizing Hormone--metabolism
Male
Middle Aged
Prostatic Neoplasms--drug therapy
Testis--drug effects
Testosterone--metabolism
Triptorelin Pamoate
Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men. [electronic resource] - The Journal of urology Nov 1989 - 1235-8 p. digital
Publication Type: Journal Article
0022-5347
10.1016/s0022-5347(17)39042-0 doi
17-alpha-Hydroxyprogesterone
Aged
Antineoplastic Agents--adverse effects
Chorionic Gonadotropin
Follicle Stimulating Hormone--metabolism
Gonadotropin-Releasing Hormone--adverse effects
Humans
Hydroxyprogesterones--metabolism
Luteinizing Hormone--metabolism
Male
Middle Aged
Prostatic Neoplasms--drug therapy
Testis--drug effects
Testosterone--metabolism
Triptorelin Pamoate